CHAMPIONS ONCOLOGY, INC. — Director's Dealing 2021

Nov 9, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CHAMPIONS ONCOLOGY, INC. (CSBR)
CIK: 0000771856
Period of Report: 2021-11-05

Reporting Person: SIDRANSKY DAVID (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-05	Option to purchase Common Stock	$10.1	A	8045	Acquired	2031-11-05	Common Stock (8045.0)	Direct

Footnotes

F1: The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 5, 2021, February 5, 2022, May 5, 2022 and August 5, 2022, respectively.